Synta Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$42.6M
Synta Pharmaceuticals General Information
Description
Developer of small molecule drugs for severe medical conditions. The company offers clinical and preclinical-stage drug candidates with mechanisms of action and novel chemical structures.
Contact Information
Website
www.syntapharma.comCorporate Office
- 45 Hartwell Avenue
- Lexington, MA 02421
- United States
Corporate Office
- 45 Hartwell Avenue
- Lexington, MA 02421
- United States
Synta Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Merger/Acquisition | 22-Jul-2016 | $42.6M | Completed | Profitable | ||
| 14. Debt Repayment | 01-Apr-2014 | Completed | Profitable | |||
| 13. 2PO | 18-Nov-2013 | Completed | Profitable | |||
| 12. Debt - General | 01-Mar-2013 | Completed | Profitable | |||
| 11. 2PO | 11-Jan-2012 | Completed | Profitable | |||
| 10. Debt - General | 01-Mar-2011 | Completed | Profitable | |||
| 9. 2PO | 08-Jan-2010 | Completed | Profitable | |||
| 8. IPO | 06-Feb-2007 | Completed | Profitable | |||
| 7. Later Stage VC (Series A) | 02-Jun-2006 | $40M | $232M | Completed | Clinical Trials - Phase 3 | |
| 6. IPO | 10-Jun-2005 | $90M | Cancelled | Clinical Trials - Phase 2 |
Synta Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Synta Pharmaceuticals Comparisons
Industry
Financing
Details
Synta Pharmaceuticals Competitors (39)
One of Synta Pharmaceuticals’s 39 competitors is Genzyme Ireland, a Corporation company based in Kilmeaden, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genzyme Ireland | Corporation | Kilmeaden, Ireland | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY |
Synta Pharmaceuticals Patents
Synta Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022079569-A | Combination therapy for the treatment of ovarian cancer | Inactive | 29-Feb-2016 | ||
| AU-2017227534-A1 | Combination therapy for treatment of ovarian cancer | Inactive | 29-Feb-2016 | ||
| AU-2023200554-A1 | Combination therapy for treatment of ovarian cancer | Inactive | 29-Feb-2016 | ||
| CA-3014680-A1 | Combination therapy for treatment of ovarian cancer | Pending | 29-Feb-2016 | ||
| EP-3423048-A1 | Combination therapy for treatment of ovarian cancer | Inactive | 29-Feb-2016 | A61K31/4196 |
Synta Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Caxton (Europe) | Hedge Fund | Minority | ||
| Gollust Management | Venture Capital | Minority | ||
| Lowenthal Capital Partners | Hedge Fund | Minority | ||
| Mountain Trail Investments | Venture Capital | Minority | ||
| Wyandanch Partners | Growth/Expansion | Minority |
Synta Pharmaceuticals Acquisitions (1)
Synta Pharmaceuticals’s most recent deal was a Reverse Merger with Madrigal Pharmaceuticals. The deal was made on 22-Jul-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | 22-Jul-2016 | Reverse Merger | Pharmaceuticals |
Synta Pharmaceuticals FAQs
-
When was Synta Pharmaceuticals founded?
Synta Pharmaceuticals was founded in 2000.
-
Where is Synta Pharmaceuticals headquartered?
Synta Pharmaceuticals is headquartered in Lexington, MA.
-
What industry is Synta Pharmaceuticals in?
Synta Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Synta Pharmaceuticals a private or public company?
Synta Pharmaceuticals is a Private company.
-
What is the current valuation of Synta Pharmaceuticals?
The current valuation of Synta Pharmaceuticals is .
-
What is Synta Pharmaceuticals’s current revenue?
The current revenue for Synta Pharmaceuticals is .
-
How much funding has Synta Pharmaceuticals raised over time?
Synta Pharmaceuticals has raised $426M.
-
Who are Synta Pharmaceuticals’s investors?
Caxton (Europe), Gollust Management, Lowenthal Capital Partners, Mountain Trail Investments, and Wyandanch Partners have invested in Synta Pharmaceuticals.
-
Who are Synta Pharmaceuticals’s competitors?
Genzyme Ireland, Pfizer (Vienna), BioMarin Pharmaceutical, Pfizer Pakistan, and Regeneron Pharmaceuticals are some of the 39 competitors of Synta Pharmaceuticals.
-
When was Synta Pharmaceuticals acquired?
Synta Pharmaceuticals was acquired on 22-Jul-2016.
-
Who acquired Synta Pharmaceuticals?
Synta Pharmaceuticals was acquired by Madrigal Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process